SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-10-076756
Filing Date
2010-04-05
Accepted
2010-04-05 16:45:55
Documents
10
Period of Report
2010-03-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 27708
2 LETTER AGREEMENT dex11.htm EX-1.1 85986
3 ARTICLES OF AMENDMENT TO AMENDED AND RESTATED ARTICLES dex31.htm EX-3.1 65071
4 FORM OF SERIES 4 PREFERRED STOCK CERTIFICATE dex41.htm EX-4.1 7601
5 FORM OF COMMON STOCK PURCHASE WARRANT dex42.htm EX-4.2 71092
6 FORM OF SECURITIES PURCHASE AGREEMENT dex101.htm EX-10.1 142956
7 PRESS RELEASE dex991.htm EX-99.1 8924
8 GRAPHIC g56493g00b65.jpg GRAPHIC 4863
9 GRAPHIC g56493g57x47.jpg GRAPHIC 20335
10 GRAPHIC g56493g97v51.jpg GRAPHIC 3115
  Complete submission text file 0001193125-10-076756.txt   450530
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12465 | Film No.: 10731636
SIC: 2834 Pharmaceutical Preparations